Dw News
@dwnews·6.3M subscribers·48.6K videos
Novavax approved in EU as fifth vaccine effective against COVID-19 | DW News
Posted
December 20, 2021
Views
68,396
Likes
886
Comments
407
Engagement
1.89%
December 20, 2021
68,396
886
407
1.89%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:20Now PlayingThe European Union's medicines regulator has approved a new coronavirus vaccine made by US biotech company Novavax. It's the fifth jab to be greenlighted for use within the EU - for those 18 and above.
The regulator said trial data showed the Novavax jab had no serious side effects. It requires two doses, three weeks apart. It showed high effectiveness against older coronavirus variants - but it is unclear how it will perform against Omicron. Novavax uses an older protein-based technology, raising hopes it can convince people who are hesitant about taking the newer mRNA vaccines.
For more news go to
Follow DW on social media:
Für Videos in deutscher Sprache besuchen Sie
#Novavax #EMA #Omicron
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
